311 related articles for article (PubMed ID: 31633252)
1. Impact of human papillomavirus status on survival and recurrence in a geographic region with a low prevalence of HPV-related cancer: A retrospective cohort study.
De Cicco R; de Melo Menezes R; Nicolau UR; Pinto CAL; Villa LL; Kowalski LP
Head Neck; 2020 Jan; 42(1):93-102. PubMed ID: 31633252
[TBL] [Abstract][Full Text] [Related]
2. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.
Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S
Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of p16 expression in oropharyngeal squamous cell carcinoma in southern Brazil.
Girardi FM; Wagner VP; Martins MD; Abentroth AL; Hauth LA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Dec; 130(6):681-691. PubMed ID: 32981865
[TBL] [Abstract][Full Text] [Related]
4. Oncologic outcomes of human papillomavirus-associated oropharynx carcinoma treated with surgery alone: A 12-institution study of 344 patients.
Ryan WR; Xu MJ; Ochoa E; Plonowska-Hirschfeld KA; Zebolsky AL; Ha PK; Bewley AF; Mallen-St Clair J; Joshi AS; Coffey CS; Faraji F; MacDonald BV; Houlton JJ; Gobillot TA; Curry JM; Philips R; Hackman TG; Richmon JD; Holcomb AJ; Coughlin AM; Panwar A; Smith RB; Herberg ME; Fakhry C; Cognetti DM
Cancer; 2021 Sep; 127(17):3092-3106. PubMed ID: 33957701
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of human papillomavirus detection and the eighth edition of the TNM classification staging system in oropharyngeal squamous cell carcinoma: A single-center Polish study.
Durzynska M; Kiprian D; Szumera-Cieckiewicz A; Leszczynski P; Florek A; Snietura M; Michalek IM; Bakula-Zalewska E; Prochorec-Sobieszek M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jun; 133(6):698-705. PubMed ID: 35165063
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas.
Vijayvargiya P; Trivedi S; Rupji M; Song H; Liu Y; Jiang R; Kaka AS; Chen GZ; Stokes W; Steuer C; Shin DM; Beitler JJ; Patel MR; Aiken A; Saba NF
Oncologist; 2022 Feb; 27(1):48-56. PubMed ID: 35305095
[TBL] [Abstract][Full Text] [Related]
8. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
Front Public Health; 2022; 10():900294. PubMed ID: 35958856
[TBL] [Abstract][Full Text] [Related]
9. Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus-Associated Oropharyngeal Cancer.
Cramer JD; Dundar Y; Hotaling J; Raza SN; Lin HS
JAMA Otolaryngol Head Neck Surg; 2019 Dec; 145(12):1105-1114. PubMed ID: 31042786
[TBL] [Abstract][Full Text] [Related]
10. Role of Human Papilloma Virus and Lifestyle Factors in Overall Survival of Patients with Oropharyngeal Squamous Cell Carcinoma.
Nishikawa D; Hanai N; Ozawa T; Kitahara T; Hasegawa Y
Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454395
[TBL] [Abstract][Full Text] [Related]
11. The role of concomitant chemoradiotherapy in AJCC 7
Lu DJ; Luu M; Nguyen AT; Shiao SL; Scher K; Mita A; Anderson E; Clair JM; Ho AS; Zumsteg ZS
Oral Oncol; 2020 Nov; 110():104882. PubMed ID: 32650257
[TBL] [Abstract][Full Text] [Related]
12. Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 staging.
Contrera KJ; Smile TD; Mahomva C; Wei W; Adelstein DJ; Broughman JR; Burkey BB; Geiger JL; Joshi NP; Ku JA; Lamarre ED; Lorenz RR; Prendes BL; Scharpf J; Schwartzman LM; Woody NM; Xiong D; Koyfman SA
Oral Oncol; 2020 Dec; 111():105030. PubMed ID: 33038751
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Smoking in Human Papillomavirus-Positive Oropharyngeal Cancer Under American Joint Committee on Cancer Eighth Edition Stage.
Chidambaram S; Nakken ER; Kennedy W; Thorstad WL; Chen SY; Pipkorn P; Zevallos JP; Mazul AL
Laryngoscope; 2020 Aug; 130(8):1961-1966. PubMed ID: 32293733
[TBL] [Abstract][Full Text] [Related]
14. A comparison of timing and patterns of treatment failure, and survival outcomes after progression between HPV+ and HPV- patients undergoing chemoradiation for oropharyngeal squamous cell carcinomas.
Laxague F; Zeng PYF; Zabihi D; Fnais N; Alshahrani M; Fung K; MacNeil D; Mendez A; Yoo J; Mymryk JS; Barrett JW; Palma DA; Nichols AC
Head Neck; 2024 Mar; 46(3):503-512. PubMed ID: 38100227
[TBL] [Abstract][Full Text] [Related]
15. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
[TBL] [Abstract][Full Text] [Related]
16. Impact of Nodal Metastases in HPV-Negative Oropharyngeal Cancer.
Chang CM; Chen MM; Bellile EL; Rozek LS; Carey TE; Spector ME; Wolf GT; Taylor JM; Chinn SB
Cancer Epidemiol Biomarkers Prev; 2022 Aug; 31(8):1554-1563. PubMed ID: 35579907
[TBL] [Abstract][Full Text] [Related]
17. Utilizing the AJCC 8
Kim SI; Lee JW; Eun YG; Lee YC
Anticancer Res; 2024 Apr; 44(4):1703-1710. PubMed ID: 38538003
[TBL] [Abstract][Full Text] [Related]
18. Disease Profile and Oncologic Outcomes After Delayed Diagnosis of Human Papillomavirus-Associated Oropharyngeal Cancer.
Yin LX; Karp EE; Elias A; O'Byrne TJ; Routman DM; Price DL; Kasperbauer JL; Neben-Wittich M; Chintakuntlawar AV; Price KA; Ma DJ; Foote RL; Moore EJ; Van Abel KM
Otolaryngol Head Neck Surg; 2021 Dec; 165(6):830-837. PubMed ID: 33752487
[TBL] [Abstract][Full Text] [Related]
19. Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer.
Baliga S; Mitchell D; Yildiz VO; Gogineni E; Konieczkowski DJ; Grecula J; Blakaj DM; Liu X; Gamez ME
J Med Virol; 2023 Feb; 95(2):e28448. PubMed ID: 36583477
[TBL] [Abstract][Full Text] [Related]
20. Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?
Yoshida EJ; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Nguyen AT; Shiao SL; Ho AS; Zumsteg ZS
Cancer; 2020 Jan; 126(1):58-66. PubMed ID: 31536144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
